Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
- PMID: 38045991
- PMCID: PMC10689005
- DOI: 10.1212/NXG.0000000000200109
Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
Erratum in
-
Erratum: Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-Analysis.Neurol Genet. 2024 Jan 10;10(1):e200131. doi: 10.1212/NXG.0000000000200131. eCollection 2024 Feb. Neurol Genet. 2024. PMID: 38213752 Free PMC article.
Abstract
Background and objectives: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%-10% of all ALS cases; however, no recent literature review or meta-analysis of this proportion (referred to throughout as "proportion fALS") has been conducted. Our objective was to estimate the proportion fALS by geographic region and to assess the effect of study characteristics on the estimates.
Methods: A comprehensive literature review was performed to identify all original studies reporting the number of fALS cases in an ALS cohort. The results were stratified by geographic region, study design (case series or population-based), and decade of study publication. Subgroup analyses were conducted according to family history criteria used to define fALS. We report pooled estimates of the proportion fALS from random-effects meta-analyses when >2 studies are available and I2 is < 90%; weighted averages and ranges are otherwise presented.
Results: The overall pooled proportion fALS based on a total 165 studies was 8% (0%, 71%). The proportion fALS was 9% (0%, 71%) among 107 case series and 5% (4%, 6%) among 58 population-based studies. Among population-based studies, proportion fALS by geographic region was 6% (5%, 7%; N = 37) for Europe, 5% (3%, 7%; N = 5) for Latin America, and 5% (4%, 7%; N = 12) for North America. Criteria used to define fALS were reported by 21 population-based studies (36%), and proportion fALS was 5% (4%, 5%; N = 9) for first-degree relative, 7% (4%, 11%; N = 4) for first or second-degree relative, and 11% (N = 1) for more distant ALS family history. Population-based studies published in the 2000s or earlier generated a lower pooled proportion fALS than studies published in the 2010s or later.
Discussion: The results suggest that variability in the reported proportion fALS in the literature may be, in part, due to the differences in geography, study design, fALS definition, and decade of case ascertainment. Few studies outside of European ancestral populations were available. The proportion fALS was marginally higher among case series compared with population-based studies, likely because of referral bias. Criteria used to define fALS were largely unreported. Consensus criteria for fALS and additional population-based studies in non-European ancestral populations are needed.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Conflict of interest statement
J. Barberio: employee of Epidemiologic Research & Methods, LLC, doctoral stipend and tuition are supported by an award to Emory University from Amgen Inc; C. Lally: employee of Epidemiologic Research and Methods; V. Kuplian: employee of and holds stock/stock options in Biogen; O. Hardiman: Science Foundation Ireland grants SFI 16/RC/3948 and 20/SP/8953, consulting fees from Cytokinetics, Wave Pharmaceuticals, Orion, Biogen, Denali, Novartis and Accelsior, Editor-in-Chief of the journal ALS and Frontotemporal Degeneration; W.D. Flanders: employee of Epidemiologic Research & Methods, LLC, employee of Rollins School of Public Health. Go to Neurology.org/NG for full disclosures.
References
LinkOut - more resources
Full Text Sources
Miscellaneous